vs
Apellis Pharmaceuticals, Inc.（APLS）与EZCORP INC（EZPW）财务数据对比。点击上方公司名可切换其他公司
EZCORP INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.9倍（$382.0M vs $199.9M），EZCORP INC净利率更高（11.6% vs -29.5%，领先41.1%），EZCORP INC同比增速更快（19.3% vs -5.9%），EZCORP INC自由现金流更多（$31.7M vs $-14.3M），过去两年EZCORP INC的营收复合增速更高（15.6% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
EZCORP是总部位于美国得克萨斯州奥斯汀的典当行运营商，业务覆盖美国及拉丁美洲地区，是美国第二大典当行运营商，仅次于Cash America International，目前在纳斯达克挂牌上市。
APLS vs EZPW — 直观对比
营收规模更大
EZPW
是对方的1.9倍
$199.9M
营收增速更快
EZPW
高出25.3%
-5.9%
净利率更高
EZPW
高出41.1%
-29.5%
自由现金流更多
EZPW
多$46.0M
$-14.3M
两年增速更快
EZPW
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $382.0M |
| 净利润 | $-59.0M | $44.3M |
| 毛利率 | — | 58.4% |
| 营业利润率 | -25.6% | 15.9% |
| 净利率 | -29.5% | 11.6% |
| 营收同比 | -5.9% | 19.3% |
| 净利润同比 | -62.2% | 42.8% |
| 每股收益（稀释后） | $-0.40 | $0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSEZPW
| Q4 25 | $199.9M | $382.0M | ||
| Q3 25 | $458.6M | $336.8M | ||
| Q2 25 | $178.5M | $311.0M | ||
| Q1 25 | $166.8M | $306.3M | ||
| Q4 24 | $212.5M | $320.2M | ||
| Q3 24 | $196.8M | $294.6M | ||
| Q2 24 | $199.7M | $281.4M | ||
| Q1 24 | $172.3M | $285.6M |
净利润APLSEZPW
| Q4 25 | $-59.0M | $44.3M | ||
| Q3 25 | $215.7M | $26.7M | ||
| Q2 25 | $-42.2M | $26.5M | ||
| Q1 25 | $-92.2M | $25.4M | ||
| Q4 24 | $-36.4M | $31.0M | ||
| Q3 24 | $-57.4M | $15.2M | ||
| Q2 24 | $-37.7M | $17.9M | ||
| Q1 24 | $-66.4M | $21.5M |
毛利率APLSEZPW
| Q4 25 | — | 58.4% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 59.1% | ||
| Q1 25 | — | 58.3% | ||
| Q4 24 | — | 57.9% | ||
| Q3 24 | — | 59.5% | ||
| Q2 24 | — | 59.2% | ||
| Q1 24 | — | 58.7% |
营业利润率APLSEZPW
| Q4 25 | -25.6% | 15.9% | ||
| Q3 25 | 48.7% | 11.0% | ||
| Q2 25 | -18.6% | 11.6% | ||
| Q1 25 | -50.0% | 11.2% | ||
| Q4 24 | -12.3% | 13.1% | ||
| Q3 24 | -24.0% | 8.8% | ||
| Q2 24 | -14.7% | 7.9% | ||
| Q1 24 | -36.0% | 9.6% |
净利率APLSEZPW
| Q4 25 | -29.5% | 11.6% | ||
| Q3 25 | 47.0% | 7.9% | ||
| Q2 25 | -23.6% | 8.5% | ||
| Q1 25 | -55.3% | 8.3% | ||
| Q4 24 | -17.1% | 9.7% | ||
| Q3 24 | -29.2% | 5.2% | ||
| Q2 24 | -18.9% | 6.4% | ||
| Q1 24 | -38.5% | 7.5% |
每股收益（稀释后）APLSEZPW
| Q4 25 | $-0.40 | $0.55 | ||
| Q3 25 | $1.67 | $0.35 | ||
| Q2 25 | $-0.33 | $0.34 | ||
| Q1 25 | $-0.74 | $0.33 | ||
| Q4 24 | $-0.30 | $0.40 | ||
| Q3 24 | $-0.46 | $0.20 | ||
| Q2 24 | $-0.30 | $0.25 | ||
| Q1 24 | $-0.54 | $0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $465.9M |
| 总债务越低越好 | — | $518.6M |
| 股东权益账面价值 | $370.1M | $1.1B |
| 总资产 | $1.1B | $2.0B |
| 负债/权益比越低杠杆越低 | — | 0.48× |
8季度趋势，按日历期对齐
现金及短期投资APLSEZPW
| Q4 25 | $466.2M | $465.9M | ||
| Q3 25 | $479.2M | $469.5M | ||
| Q2 25 | $370.0M | $472.1M | ||
| Q1 25 | $358.4M | $505.2M | ||
| Q4 24 | $411.3M | $174.5M | ||
| Q3 24 | $396.9M | $170.5M | ||
| Q2 24 | $360.1M | $218.0M | ||
| Q1 24 | $325.9M | $229.1M |
总债务APLSEZPW
| Q4 25 | — | $518.6M | ||
| Q3 25 | — | $518.1M | ||
| Q2 25 | — | $517.6M | ||
| Q1 25 | — | $620.5M | ||
| Q4 24 | — | $327.7M | ||
| Q3 24 | — | $327.3M | ||
| Q2 24 | — | $361.3M | ||
| Q1 24 | $93.1M | $360.9M |
股东权益APLSEZPW
| Q4 25 | $370.1M | $1.1B | ||
| Q3 25 | $401.2M | $1.0B | ||
| Q2 25 | $156.3M | $990.1M | ||
| Q1 25 | $164.2M | $851.6M | ||
| Q4 24 | $228.5M | $823.9M | ||
| Q3 24 | $237.1M | $804.6M | ||
| Q2 24 | $264.3M | $801.5M | ||
| Q1 24 | $266.7M | $800.4M |
总资产APLSEZPW
| Q4 25 | $1.1B | $2.0B | ||
| Q3 25 | $1.1B | $2.0B | ||
| Q2 25 | $821.4M | $1.9B | ||
| Q1 25 | $807.3M | $1.8B | ||
| Q4 24 | $885.1M | $1.5B | ||
| Q3 24 | $901.9M | $1.5B | ||
| Q2 24 | $904.5M | $1.5B | ||
| Q1 24 | $831.9M | $1.5B |
负债/权益比APLSEZPW
| Q4 25 | — | 0.48× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.73× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | 0.35× | 0.45× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $39.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $31.7M |
| 自由现金流率自由现金流/营收 | -7.1% | 8.3% |
| 资本支出强度资本支出/营收 | 0.1% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $121.7M |
8季度趋势，按日历期对齐
经营现金流APLSEZPW
| Q4 25 | $-14.2M | $39.1M | ||
| Q3 25 | $108.5M | $51.3M | ||
| Q2 25 | $4.4M | $34.8M | ||
| Q1 25 | $-53.4M | $36.9M | ||
| Q4 24 | $19.4M | $26.0M | ||
| Q3 24 | $34.1M | $43.3M | ||
| Q2 24 | $-8.3M | $33.7M | ||
| Q1 24 | $-133.0M | $15.1M |
自由现金流APLSEZPW
| Q4 25 | $-14.3M | $31.7M | ||
| Q3 25 | $108.3M | $35.7M | ||
| Q2 25 | $4.4M | $25.7M | ||
| Q1 25 | $-53.4M | $28.6M | ||
| Q4 24 | $19.3M | $20.4M | ||
| Q3 24 | — | $24.4M | ||
| Q2 24 | $-8.4M | $30.5M | ||
| Q1 24 | $-133.3M | $8.6M |
自由现金流率APLSEZPW
| Q4 25 | -7.1% | 8.3% | ||
| Q3 25 | 23.6% | 10.6% | ||
| Q2 25 | 2.5% | 8.3% | ||
| Q1 25 | -32.0% | 9.3% | ||
| Q4 24 | 9.1% | 6.4% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | -4.2% | 10.8% | ||
| Q1 24 | -77.3% | 3.0% |
资本支出强度APLSEZPW
| Q4 25 | 0.1% | 2.0% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.0% | 2.7% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.0% | 6.4% | ||
| Q2 24 | 0.0% | 1.1% | ||
| Q1 24 | 0.2% | 2.3% |
现金转化率APLSEZPW
| Q4 25 | — | 0.88× | ||
| Q3 25 | 0.50× | 1.92× | ||
| Q2 25 | — | 1.31× | ||
| Q1 25 | — | 1.45× | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 1.88× | ||
| Q1 24 | — | 0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
EZPW
| Merchandise | $210.1M | 55% |
| Pawn Service | $131.9M | 35% |
| Jewelry Scrap | $39.9M | 10% |
